Open Access

Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1

  • Authors:
    • Zhanpeng Luo
    • Dawei Li
    • Xiaobo Luo
    • Litao Li
    • Suxi Gu
    • Long Yu
    • Yuanzheng Ma
  • View Affiliations

  • Published online on: February 13, 2018     https://doi.org/10.3892/ol.2018.8032
  • Pages: 5593-5601
  • Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The present study aimed to determine the mechanisms of action of curcumin in osteosarcoma. Human osteosarcoma U‑2 OS cells was purchased from the Cell Bank of the Chinese Academy of Sciences. RNA sequencing analysis was performed for 2 curcumin‑treated samples and 2 control samples using Illumina deep sequencing technology. The differentially expressed genes were identified using Cufflink software. Enrichment and protein‑protein interaction network analyses were performed separately using cluster Profiler package and Cytoscape software to identify key genes. Then, the mRNA levels of key genes were detected by quantitative reverse transcription polymerase chain reaction (RT‑qPCR) in U‑2 OS cells. Finally, cell apoptosis, proliferation, migration and invasion arrays were performed. In total, 201 DEGs were identified in the curcumin‑treated group. EEF1A1 (degree=88), ATF7IP, HIF1A, SMAD7, CLTC, MCM10, ITPR1, ADAM15, WWP2 and ATP5C1, which were enriched in ‘biological process’, exhibited higher degrees than other genes in the PPI network. RT‑qPCR demonstrated that treatment with curcumin was able to significantly increase the levels of CLTC and ITPR1 mRNA in curcumin‑treated cells compared with control. In addition, targeting ITPR1 with curcumin significantly promoted apoptosis and suppressed proliferation, migration and invasion. Targeting ITPR1 via curcumin may serve an anticancer role by mediating apoptosis, proliferation, migration and invasion in U-2 OS cells.

References

1 

Broadhead ML, Clark J, Myers DE, Dass CR and Choong PF: The molecular pathogenesis of osteosarcoma: A review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI

2 

Ottaviani G and Jaffe N: The epidemiology of osteosarcoma = Pediatric and adolescent osteosarcoma. Springer; pp. 3–13. 2010

3 

He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ and Feng JX: Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev. 15:5967–5976. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Deng BY, Hua YQ and Cai ZD: Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma. Eur J Med Res. 18:572013. View Article : Google Scholar : PubMed/NCBI

5 

Chen Y, Liu WH, Chen BL, Fan L, Han Y, Wang G, Hu DL, Tan ZR, Zhou G, Cao S and Zhou HH: Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother. 44:1038–1045. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Rattigan Y and Maitra A: Metabolomic profiling of curcumin effects on pancreatic cancer: Insights into anti-tumor activity. Pancreatology. 13:e682013. View Article : Google Scholar

7 

Motterlini R, Foresti R, Bassi R and Green CJ: Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 28:1303–1312. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Chattopadhyay I, Biswas K, Bandyopadhyay U and Banerjee RK: Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 87:44–53. 2004.

9 

Qiong L and Ran X: Pharmacological effects of curcumin and bladder cancer treatment research progress. Zhongyaoyao li yulinchuang. 3:0502012.

10 

Walters DK, Muff R, Langsam B, Born W and Fuchs B: Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs. 26:289–297. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philip PA and Sarkar FH: Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One. 6:e178502011. View Article : Google Scholar : PubMed/NCBI

12 

Jaiswal AS, Marlow BP, Gupta N and Narayan S: Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene. 21:8414–8427. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Fossey SL, Bear MD, Lin J, Li C, Schwartz EB, Li PK, Fuchs JR, Fenger J, Kisseberth WC and London CA: The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression and induces apoptosis in osteosarcoma cell lines. BMC Cancer. 11:1122011. View Article : Google Scholar : PubMed/NCBI

14 

Chang Z, Xing J and Yu X: Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway. Tumour Biol. 35:753–758. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Leow PC, Tian Q, Ong ZY, Yang Z and Ee PL: Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells. Invest New Drugs. 28:766–782. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Wang Z, Gerstein M and Snyder M: RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Ozsolak F and Milos PM: RNA sequencing: Advances, challenges and opportunities. Nat Rev Genet. 12:87–98. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Trapnell C, Pachter L and Salzberg SL: TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics. 25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Langmead B: Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics. Dec;2010. View Article : Google Scholar : PubMed/NCBI

20 

Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, et al: The UCSC genome browser database: Update 2011. Nucleic Acids Res. 39(Database Issue): D876–D882. 2010.PubMed/NCBI

21 

Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL and Pachter L: Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 31:46–53. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Gene Ontology Consortium: The gene ontology (GO) project in 2006. Nucleic Acids Res. 34(Database Issue): D322–D326. 2006.PubMed/NCBI

23 

Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T and Yamanishi Y: KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36(Database Issue): D480–D484. 2008.PubMed/NCBI

24 

Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 57:289–300. 1995.

26 

Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, et al: Human protein reference database-2009 update. Nucleic Acids Res. 37(Database Issue): D767–D772. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Chau NM, Rogers P, Aherne W, Carroll V, Collins I, McDonald E, Workman P and Ashcroft M: Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res. 65:4918–4928. 2005. View Article : Google Scholar : PubMed/NCBI

30 

Wu Q, Yang SH, Ye SN and Wang RY: Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma. Zhonghua Yi Xue Za Zhi. 85:409–413. 2005.(In Chinese). PubMed/NCBI

31 

El Naggar A, Clarkson P, Zhang F, Mathers J, Tognon C and Sorensen PH: Expression and stability of hypoxia inducible factor 1α in osteosarcoma. Pediatr Blood Cancer. 59:1215–1222. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Chen WL, Feng HJ and Li HG: Expression and significance of hypoxemia-inducible factor-1alpha in osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 106:254–257. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Selga E, Oleaga C, Ramírez S, de Almagro MC, Noé V and Ciudad CJ: Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med. 1:832009. View Article : Google Scholar : PubMed/NCBI

34 

Ruest LB, Marcotte R and Wang E: Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J Biol Chem. 277:5418–5425. 2002. View Article : Google Scholar : PubMed/NCBI

35 

Blanch A, Robinson F, Watson IR, Cheng LS and Irwin MS: Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. PLoS One. 8:e664362013. View Article : Google Scholar : PubMed/NCBI

36 

Kastan MB, Canman CE and Leonard CJ: P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev. 14:3–15. 1995. View Article : Google Scholar : PubMed/NCBI

37 

Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 2:305–316. 1998. View Article : Google Scholar : PubMed/NCBI

38 

Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H and Rosier RN: Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res. 312:40–50. 2006. View Article : Google Scholar : PubMed/NCBI

39 

Lamora A, Talbot J, Bougras G, Amiaud J, Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann MF, et al: Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin Cancer Res. 20:5097–5112. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Won KY, Kim YW and Park YK: Expression of Smad and its signalling cascade in osteosarcoma. Pathology. 42:242–247. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Kunnumakkara AB, Anand P and Aggarwal BB: Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar : PubMed/NCBI

42 

Lee DS, Lee MK and Kim JH: Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res. 29:5039–5044. 2009.PubMed/NCBI

43 

Jin S, Xu HG, Shen JN, Chen XW, Wang H and Zhou JG: Apoptotic effects of curcumin on human osteosarcoma U2OS cells. Orhop Surg. 1:144–152. 2009. View Article : Google Scholar

44 

Li Y, Zhang J, Ma D, Zhang L, Si M, Yin H and Li J: Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J. 279:2247–2259. 2012. View Article : Google Scholar : PubMed/NCBI

45 

Li C, Wang X, Vais H, Thompson CB, Foskett JK and White C: Apoptosis regulation by Bcl-x(L) modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating. Proc Natl Acad Sci USA. 104:pp. 12565–12570. 2007; View Article : Google Scholar : PubMed/NCBI

46 

Orrenius S, Zhivotovsky B and Nicotera P: Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol Cell Biol. 4:552–565. 2003. View Article : Google Scholar : PubMed/NCBI

47 

Boehning D, Patterson RL and Snyder SH: Apoptosis and calcium: New roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle. 3:250–252. 2004. View Article : Google Scholar

48 

Bradford PG, Maglich JM and Kirkwood KL: IL-1 beta increases type 1 inositol trisphosphate receptor expression and IL-6 secretory capacity in osteoblastic cell cultures. Mol Cell Biol Res Commun. 3:73–75. 2000. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Luo, Z., Li, D., Luo, X., Li, L., Gu, S., Yu, L., & Ma, Y. (2018). Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1. Oncology Letters, 15, 5593-5601. https://doi.org/10.3892/ol.2018.8032
MLA
Luo, Z., Li, D., Luo, X., Li, L., Gu, S., Yu, L., Ma, Y."Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1". Oncology Letters 15.4 (2018): 5593-5601.
Chicago
Luo, Z., Li, D., Luo, X., Li, L., Gu, S., Yu, L., Ma, Y."Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1". Oncology Letters 15, no. 4 (2018): 5593-5601. https://doi.org/10.3892/ol.2018.8032